Tower Research Capital LLC (Trc) Anebulo Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,326 shares of ANEB stock, worth $4,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,326
Previous 2,694
23.46%
Holding current value
$4,423
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
9.92MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$20.6 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$4.04 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$3.36 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$841,2460.13% of portfolio
-
Morgan Stanley New York, NY420KShares$558,5920.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $34.1M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...